Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated aspirin formulation. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to delay absorption until the drug reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* Pain relief (mild to moderate)
* Fever reduction
* Inflammation reduction
* Cardiovascular prophylaxis (e.g., secondary prevention of myocardial infarction, stroke)
## Adult Dosing
Dosing is highly indication-dependent.
* **Pain/Fever/Inflammation:** Typically 325 mg to 650 mg orally every 4 to 6 hours as needed. Maximum dose generally 4000 mg per day.
* **Cardiovascular Prophylaxis:** Typically 75 mg to 325 mg orally once daily.
## Pediatric Dosing
**Generally not recommended for use in children and teenagers with viral infections due to the risk of Reye's syndrome.** Specific indications and dosing in pediatric populations should be guided by specialist consultation and available evidence.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised. Patients with severe impairment should be monitored closely for adverse effects.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.
* Bleeding disorders (e.g., hemophilia, thrombocytopenia).
* Active peptic ulcer disease or gastrointestinal bleeding.
* Children and teenagers with viral infections.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding time, bruising, epistaxis.
* **Hypersensitivity:** Bronchospasm, angioedema, rash.
* **Renal:** Reduced renal function, interstitial nephritis.
* **Hepatic:** Elevated liver enzymes.
* **Other:** Tinnitus, dizziness, headache.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs (including COX-2 inhibitors):** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers):** Aspirin may reduce their efficacy.
* **Methotrexate:** Aspirin can increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin may reduce the efficacy of uricosuric agents.
* **Alcohol:** Increased risk of GI irritation and bleeding.
## Monitoring
* **GI Symptoms:** Monitor for signs of dyspepsia, abdominal pain, or bleeding.
* **Bleeding:** Monitor for increased bruising, epistaxis, or signs of occult GI bleeding.
* **Renal Function:** Particularly in patients with pre-existing renal disease or those taking concomitant nephrotoxic agents.
* **Hepatic Function:** May be considered in patients with underlying liver disease or those on long-term, high-dose therapy.
* **Tinnitus:** Can be an early sign of salicylate toxicity.
## Clinical Pearls
* The enteric coating delays the onset of action and may reduce gastric upset but does not eliminate the risk of GI bleeding.
* Aspirin should be taken with food or milk to further minimize GI irritation.
* Patients should be advised to avoid alcohol while taking aspirin.
* For acute pain or fever, the onset of action may be slower compared to non-enteric-coated aspirin.
* In situations requiring rapid platelet inhibition (e.g., acute coronary syndrome), non-enteric-coated aspirin may be preferred for faster absorption.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most current and comprehensive data before making any clinical decisions.
